Indicon Società Benefit (SB) is an innovative startup focused on innovation management in lifescience. With a mission to study, understand, and develop high-tech solutions in the healthcare and lifescience sectors, they are at the forefront of revolutionizing these industries. Their work spans various forms of innovation in lifescience, including technology transfer in health, digital health, digital therapies, and artificial intelligence. Founded in 2021 and headquartered in Italy, Indicon SB aims to strategically support the growth and innovation of startups and corporations in the lifescience sector. As of now, there is no publicly disclosed information available about their last investment and the investors involved. This indicates an opportunity for potential investors to explore collaboration and investment possibilities with this promising startup.
There is no investment information
No recent news or press coverage available for Indicon Società Benefit (SB).